Liraglutide attenuates hepatic iron levels and ferroptosis in db/db mice

References

• Khan MNA, Khan FA, Sultana S, et al. Impact of new diagnostic criteria of diabetes mellitus. J Coll Physicians Surg Pak. 2007;17(6):327–330.
   PubMed Web of Science ®Google Scholar
• Khunti K, Gavin JR 3rd, Boulton AJM, et al. The Berlin declaration: a call to improve early actions related to type 2 diabetes. Why is primary care important? Care Diabetes. 2018;12(5):383–392.
   PubMed Web of Science ®Google Scholar
• Ming H. Diabetic neuropathy: what now? What’s next? Life Res. 2021;4:10–17.
   Google Scholar
• Ebert EC. Gastrointestinal complications of diabetes mellitus. Dis Mon. 2005;51(12):620–663.
   PubMed Web of Science ®Google Scholar
• Meshkani R, Adeli K. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin Biochem. 2009;42(13–14):1331–1346.
   PubMed Web of Science ®Google Scholar
• Shakil A, Church RJ, Rao SS. Gastrointestinal complications of diabetes. Am Fam Physician. 2008;77(12):1697–1702.
   PubMed Web of Science ®Google Scholar
• Hazlehurst JM, Woods C, Marjot T, et al. Non-alcoholic fatty liver disease and diabetes. Metabolism. 2016;65(8):1096–1108.
   PubMed Web of Science ®Google Scholar
• Chung W, Promrat K, Wands J. Clinical implications, diagnosis, and management of diabetes in patients with chronic liver diseases. World J Hepatol. 2020;12(9):533–557.
   PubMed Web of Science ®Google Scholar
• Lonardo A, Nascimbeni F, Mantovani A, et al. Hypertension, diabetes, atherosclerosis and NASH: cause or consequence? J Hepatol. 2018;68(2):335–352.
   PubMed Web of Science ®Google Scholar
• McPherson S, Hardy T, Henderson E, et al. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. J Hepatol. 2015;62(5):1148–1155.
   PubMed Web of Science ®Google Scholar
• Ma W, Jia L, Xiong Q, et al. Iron overload protects from obesity by ferroptosis. Foods. 2021;10(8):1787.
   PubMed Web of Science ®Google Scholar
• Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–1072.
   PubMed Web of Science ®Google Scholar
• Hou W, Xie Y, Song X, et al. Autophagy promotes ferroptosis by degradation of ferritin. Autophagy. 2016;12(8):1425–1428.
   PubMed Web of Science ®Google Scholar
• Gao M, Monian P, Pan Q, et al. Ferroptosis is an autophagic cell death process. Cell Res. 2016;26(9):1021–1032.
   PubMed Web of Science ®Google Scholar
• Feng X, Wang S, Sun Z, et al. Ferroptosis enhanced diabetic renal tubular injury via HIF-1alpha/HO-1 pathway in db/db mice. Front Endocrinol (Lausanne). 2021;12:626390.
   PubMed Web of Science ®Google Scholar
• Luo EF, Li HX, Qin YH, et al. Role of ferroptosis in the process of diabetes-induced endothelial dysfunction. World J Diabetes. 2021;12(2):124–137.
   PubMed Web of Science ®Google Scholar
• Hao L, Mi J, Song L, et al. SLC40A1 mediates ferroptosis and cognitive dysfunction in Type 1 diabetes. Neuroscience. 2021;463:216–226.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Duan P, Song H, et al. Downregulation of Circular RNA PSEN1 ameliorates ferroptosis of the high glucose treated retinal pigment epithelial cells via miR-200b-3p/cofilin-2 axis. Bioengineered. 2021;12(2):12555–12567.
   PubMed Web of Science ®Google Scholar
• Pham H, Hui H, Morvaridi S, et al. 3rd et al: a bitter pill for type 2 diabetes? The activation of bitter taste receptor TAS2R38 can stimulate GLP-1 release from enteroendocrine L-cells. Biochem Biophys Res Commun. 2016;475(3):295–300.
   PubMed Web of Science ®Google Scholar
• Tella SH, Rendell MS. Glucagon-like polypeptide agonists in type 2 diabetes mellitus: efficacy and tolerability, a balance. Ther Adv Endocrinol Metab. 2015;6(3):109–134.
   PubMed Web of Science ®Google Scholar
• Buse JB, Rosenstock J, Sesti G, et al. Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6). Lancet. 2009;374(9683):39–47.
   PubMed Web of Science ®Google Scholar
• Knudsen LB, Lau J. The discovery and development of liraglutide and Semaglutide. Front Endocrinol (Lausanne). 2019;10:155.
   PubMed Web of Science ®Google Scholar
• Zander M, Madsbad S, Madsen JL, et al. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study. Lancet. 2002;359(9309):824–830.
   PubMed Web of Science ®Google Scholar
• Zhang YL, Hernandez-Ono A, Siri P, et al. Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis. J Biol Chem. 2006;281(49):37603–37615.
   PubMed Web of Science ®Google Scholar
• Tetri LH, Basaranoglu M, Brunt EM, et al. Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am J Physiol Gastrointest Liver Physiol. 2008;295(5):G987–995.
   PubMed Web of Science ®Google Scholar
• An JR, Su JN, Sun GY, et al. Liraglutide alleviates cognitive deficit in db/db Mice: involvement in oxidative stress, iron overload, and ferroptosis. Neurochem Res. 2022;47(2):279–294.
   PubMed Web of Science ®Google Scholar
• Altamura S, Mudder K, Schlotterer A, et al. Iron aggravates hepatic insulin resistance in the absence of inflammation in a novel db/db mouse model with iron overload. Mol Metab. 2021;51:101235.
   PubMed Web of Science ®Google Scholar
• Wang YQ, Chang SY, Wu Q, et al. The protective role of mitochondrial ferritin on erastin-induced ferroptosis. Front Aging Neurosci. 2016;8:308.
   PubMed Web of Science ®Google Scholar
• Zuo Y, Xie J, Li X, et al. Ferritinophagy-mediated ferroptosis involved in paraquat-induced neurotoxicity of dopaminergic neurons: implication for neurotoxicity in PD. Oxid Med Cell Longev. 2021;2021:9961628.
   PubMedGoogle Scholar
• Hayden MR. Type 2 diabetes mellitus increases the risk of late-onset alzheimer’s disease: ultrastructural remodeling of the neurovascular unit and diabetic gliopathy. Brain Sci. 2019;9(10):262.
   PubMed Web of Science ®Google Scholar
• Ip W, Shao W, Chiang YT, et al. GLP-1-derived nonapeptide GLP-1(28-36)amide represses hepatic gluconeogenic gene expression and improves pyruvate tolerance in high-fat diet-fed mice. Am J Physiol Endocrinol Metab. 2013;305(11):E1348–1358.
   PubMed Web of Science ®Google Scholar
• Wahren J, Ekberg K. Splanchnic regulation of glucose production. Annu Rev Nutr. 2007;27:329–345.
   PubMed Web of Science ®Google Scholar
• Satapati S, Kucejova B, Duarte JA, et al. Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver. J Clin Invest. 2015;125(12):4447–4462.
   PubMed Web of Science ®Google Scholar
• Mao ZJ, Lin M, Zhang X, et al. Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 Cells via regulation of the gluconeogenesis signaling pathway. Front Pharmacol. 2019;10:1508.
   PubMed Web of Science ®Google Scholar
• Briand F, Brousseau E, Maupoint J, et al. Liraglutide shows superior cardiometabolic benefits than lorcaserin in a novel free choice diet-induced obese rat model. Eur J Pharmacol. 2020;882:173316.
   PubMed Web of Science ®Google Scholar
• Li X, Jiao Y, Xing Y, et al. Diabetes mellitus and risk of hepatic fibrosis/cirrhosis. Biomed Res Int. 2019;2019:5308308.
   PubMed Web of Science ®Google Scholar
• Shimizu M, Suzuki K, Kato K, et al. Evaluation of the effects of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease. Diabetes Obes Metab. 2019;21(2):285–292.
   PubMed Web of Science ®Google Scholar
• Fujii H, Kawada N. Japan study group of Nafld J-N: the role of insulin resistance and diabetes in nonalcoholic fatty liver disease. Int J Mol Sci. 2020;21(11):3863.
   PubMed Web of Science ®Google Scholar
• Sugimoto R, Enjoji M, Kohjima M, et al. High glucose stimulates hepatic stellate cells to proliferate and to produce collagen through free radical production and activation of mitogen-activated protein kinase. Liver Int. 2005;25(5):1018–1026.
   PubMed Web of Science ®Google Scholar
• Lin J, Chen A. Curcumin diminishes the impacts of hyperglycemia on the activation of hepatic stellate cells by suppressing membrane translocation and gene expression of glucose transporter-2. Mol Cell Endocrinol. 2011;333(2):160–171.
   PubMed Web of Science ®Google Scholar
• Choi SS, Syn WK, Karaca GF, et al. Leptin promotes the myofibroblastic phenotype in hepatic stellate cells by activating the hedgehog pathway. J Biol Chem. 2010;285(47):36551–36560.
   PubMed Web of Science ®Google Scholar
• Ikeda N, Murata S, Maruyama T, et al. Platelet-derived adenosine 5’-triphosphate suppresses activation of human hepatic stellate cell: in vitro study. Hepatol Res. 2012;42(1):91–102.
   PubMed Web of Science ®Google Scholar
• Feng WH, Bi Y, Li P, et al. Effects of liraglutide, metformin and gliclazide on body composition in patients with both type 2 diabetes and non-alcoholic fatty liver disease: a randomized trial. J Diabetes Investig. 2019;10(2):399–407.
   PubMed Web of Science ®Google Scholar
• de Mesquita FC, Guixe-Muntet S, Fernandez-Iglesias A, et al. Liraglutide improves liver microvascular dysfunction in cirrhosis: evidence from translational studies. Sci Rep. 2017;7(1):3255.
   PubMed Web of Science ®Google Scholar
• Wang Y, Feng F, He W, et al. miR-188-3p abolishes germacrone-mediated podocyte protection in a mouse model of diabetic nephropathy in type I diabetes through triggering mitochondrial injury. Bioengineered. 2022;13(1):774–788.
   PubMed Web of Science ®Google Scholar
• Maritim AC, Sanders RA, Watkins JB 3rd:. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003;17(1):24–38.
   PubMed Web of Science ®Google Scholar
• Ying W. NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid Redox Signal. 2008;10(2):179–206.
   PubMed Web of Science ®Google Scholar
• Tsikas D. Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: analytical and biological challenges. Anal Biochem. 2017;524:13–30.
   PubMed Web of Science ®Google Scholar
• Kalyanaraman B. Teaching the basics of redox biology to medical and graduate students: oxidants, antioxidants and disease mechanisms. Redox Biol. 2013;1::244–257.
   PubMed Web of Science ®Google Scholar
• Xiao M, Zhong H, Xia L, et al. Pathophysiology of mitochondrial lipid oxidation: role of 4-hydroxynonenal (4-HNE) and other bioactive lipids in mitochondria. Free Radic Biol Med. 2017;111::316–327.
   PubMed Web of Science ®Google Scholar
• Wang X, Fang X, Zheng W, et al. Genetic support of a causal relationship between iron status and type 2 diabetes: a mendelian randomization study. J Clin Endocrinol Metab. 2021;106(11):e4641–e4651.
   PubMed Web of Science ®Google Scholar
• Latunde-Dada GO. Ferroptosis: role of lipid peroxidation, iron and ferritinophagy. Biochim Biophys Acta Gen Subj. 2017;1861(8):1893–1900.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang F, Li D, et al. Transferrin receptor-mediated reactive oxygen species promotes ferroptosis of KGN cells via regulating NADPH oxidase 1/PTEN induced kinase 1/acyl-CoA synthetase long chain family member 4 signaling. Bioengineered. 2021;12(1):4983–4994.
   PubMed Web of Science ®Google Scholar
• Anderson ER, Shah YM. Iron homeostasis in the liver. Compr Physiol. 2013;3(1):315–330.
   PubMed Web of Science ®Google Scholar
• Gomme PT, McCann KB, Bertolini J. Transferrin: structure, function and potential therapeutic actions. Drug Discov Today. 2005;10(4):267–273.
   PubMed Web of Science ®Google Scholar
• Petrat F, Rauen U, de Groot H. Determination of the chelatable iron pool of isolated rat hepatocytes by digital fluorescence microscopy using the fluorescent probe, phen green SK. Hepatology. 1999;29(4):1171–1179.
   PubMed Web of Science ®Google Scholar
• Stockwell BR, Friedmann Angeli JP, Bayir H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171(2):273–285.
   PubMed Web of Science ®Google Scholar
• Yang WS, Stockwell BR. Ferroptosis: death by Lipid Peroxidation. Trends Cell Biol. 2016;26(3):165–176.
   PubMed Web of Science ®Google Scholar
• Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12(8):599–620.
   PubMed Web of Science ®Google Scholar
• Lu SC. Glutathione synthesis. Biochim Biophys Acta. 2013;1830(5):3143–3153.
   PubMed Web of Science ®Google Scholar
• Angeli JPF, Shah R, Pratt DA, et al. Ferroptosis inhibition: mechanisms and opportunities. Trends Pharmacol Sci. 2017;38(5):489–498.
   PubMed Web of Science ®Google Scholar
• Sato M, Kusumi R, Hamashima S, et al. The ferroptosis inducer erastin irreversibly inhibits system xc- and synergizes with cisplatin to increase cisplatin’s cytotoxicity in cancer cells. Sci Rep. 2018;8(1):968.
   PubMed Web of Science ®Google Scholar
• Chang LC, Chiang SK, Chen SE, et al. Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis. Cancer Lett. 2018;416:124–137.
   PubMed Web of Science ®Google Scholar
• Loboda A, Damulewicz M, Pyza E, et al. Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol Life Sci. 2016;73(17):3221–3247.
   PubMed Web of Science ®Google Scholar
• Oh YS, Jun HS, Angeli JPF, et al. Effects of glucagon-like peptide-1 on oxidative stress and Nrf2 signaling. Int J Mol Sci. 2017;19(1):26.
   PubMed Web of Science ®Google Scholar
• Kerins MJ, Ooi A. The Roles of NRF2 in Modulating Cellular Iron Homeostasis. Antioxid Redox Signal. 2018;29(17):1756–1773.
   PubMed Web of Science ®Google Scholar
• Dodson M, Castro-Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 2019;23:101107.
   PubMed Web of Science ®Google Scholar
• Mahmoud AM, Hozayen WG, Ramadan SM. Berberine ameliorates methotrexate-induced liver injury by activating Nrf2/HO-1 pathway and PPARgamma, and suppressing oxidative stress and apoptosis in rats. Biomed Pharmacother. 2017;94:280–291.
   PubMed Web of Science ®Google Scholar
• Deng C, Cao J, Han J, et al. Liraglutide activates the Nrf2/HO-1 antioxidant pathway and protects brain nerve cells against cerebral ischemia in diabetic rats. Comput Intell Neurosci. 2018;2018:3094504.
   PubMed Web of Science ®Google Scholar